Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Generic schizophrenia drug put to the test in healthy volunteers

NCT ID NCT07266792

First seen Jan 04, 2026 · Last updated May 23, 2026 · Updated 17 times

Summary

This study checked if a generic 4 mg brexpiprazole tablet works the same as the brand-name drug (Rxulti) in 36 healthy adults aged 45 to 65. Participants took one dose of each drug under fasting conditions, and researchers measured drug levels in the blood to compare them. The goal was to ensure the generic version is equally effective and safe.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SCHIZOPHRENIA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Cliantha Research Limited

    Ahmedabad, Gujarat, 382210, India

Conditions

Explore the condition pages connected to this study.